Manuela Pelmus - Publications

Clinical Validation of Digital PCR-Based ctDNA Detection for Risk Stratification in Residual Triple-Negative Breast Cancer: TRICIA Trial Results.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 07, 2025

Tumour nuclear size heterogeneity as a biomarker for post-radiotherapy outcomes in gynecological malignancies.

Journal: Physics and imaging in radiation oncology

Published: January 29, 2025

Machine learning for prediction of concurrent endometrial carcinoma in patients diagnosed with endometrial intraepithelial neoplasia.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: November 06, 2023

The Mutational Spectrum of Pre- and Post-Neoadjuvant Chemotherapy Triple-Negative Breast Cancers.

Journal: Genes

Published: November 04, 2023

Functional and phenotypic consequences of an unusual inversion in MSH2.

Journal: Familial cancer

Published: August 15, 2023

Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia?

Journal: Gynecologic oncology

Published: August 21, 2022

Margin Status and Local Recurrence in Phyllodes Tumours of the Breast: A Canadian Series.

Journal: Annals of surgical oncology

Published: July 25, 2022

Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.

Journal: Gynecologic oncology

Published: January 31, 2021

Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer.

Journal: Scientific reports

Published: May 22, 2020

Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsy.

Journal: Gynecologic oncology reports

Published: September 12, 2019

Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors.

Journal: Gynecologic oncology reports

Published: January 02, 2018

Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer.

Journal: Gynecologic oncology

Published: July 24, 2017